Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Futaba ( (JP:6986) ) has provided an update.
Futaba reported nine-month net sales to December 31, 2025 of ¥31.7 billion, down 12.5% year on year, and booked an operating loss of ¥1.5 billion and an ordinary loss of ¥503 million, even as profit attributable to owners of the parent increased 32.4% to ¥1.07 billion and comprehensive income surged. The company reaffirmed its full-year forecast for lower sales and a continued operating loss in the fiscal year ending March 31, 2026, while maintaining its planned annual dividend of ¥10 per share and slightly strengthening its financial position with higher total assets and net assets.
Futaba’s removal of one overseas subsidiary from the scope of consolidation and its ability to stay profitable at the bottom line despite operating losses highlight ongoing restructuring and cost-control efforts. For stakeholders, the combination of shrinking revenue, persistent operating losses, but sustained dividends and improved equity underscores a cautious outlook, with management prioritizing balance sheet resilience and shareholder returns amid a challenging operating environment.
The most recent analyst rating on (JP:6986) stock is a Buy with a Yen829.00 price target. To see the full list of analyst forecasts on Futaba stock, see the JP:6986 Stock Forecast page.
More about Futaba
Futaba Corporation is a Japan-based manufacturer listed on the Tokyo Stock Exchange, operating under Japanese GAAP. The company is active in electronic components and related products, supplying industrial and consumer markets, and maintains a solid equity-to-asset ratio above 76%, indicating a relatively strong balance sheet position.
Average Trading Volume: 239,928
Technical Sentiment Signal: Buy
Current Market Cap: Yen31.98B
Find detailed analytics on 6986 stock on TipRanks’ Stock Analysis page.

